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Abstract
Species ranging from Chlamydomonas to humans possess the heterotrimeric kinesin-II holoenzyme composed of two
different motor subunits and one non-motor accessory subunit. An important function of kinesin-II is that it transports the
components needed for the construction and maintenance of cilia and flagella from the site of synthesis in the cell body to the
site of growth at the distal tip. Recent work suggests that kinesin-II does not directly interact with these components, but
rather via a large protein complex, which has been termed a raft (intraflagellar transport (IFT)). While ciliary transport is the
best-established function for kinesin-II, evidence has been reported for possible roles in neuronal transport, melanosome
transport, the secretory pathway and during mitosis. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
Microtubule motors use energy derived from ATP
hydrolysis to translocate unidirectionally along mi-
crotubules and to perform many di¡erent cellular
transport functions. In most interphase cells, the mi-
crotubules are oriented with their minus ends at the
center of the cell and their plus ends oriented toward
the cell periphery. Kinesin and dynein motors use
these microtubules to localize cellular organelles
such as the Golgi apparatus, the endoplasmic retic-
ulum (ER), mitochondria and lysosomes and to
move vesicular tra⁄c throughout the cell. During
mitosis, microtubule motors also ensure that equal
segregation of genetic material between two daughter
cells occurs reliably (for recent reviews of mitotic
motors see [1,2]). Neurons use microtubule motors
to sort and transport material that is synthesized
within the cell body into and along their extensive
dendritic and axonal processes (for recent reviews see
[3,4]). Finally, molecular motors are used for con-
struction, maintenance and movement of £agella
and cilia, which are themselves modi¢ed microtubule
arrays. The KIF3 kinesin family forms the kinesin-II
holoenzyme and has now been identi¢ed in species
ranging from Chlamydomonas to humans. Consider-
able data implicate KIF3 family members in many
cellular processes. This review will describe the data
that have led to these ideas.
2. The KIF3 family
The kinesin-II holoenzyme was originally puri¢ed
biochemically from sea urchin embryo extracts as a
heterotrimeric holoenzyme [5]. The term kinesin-II is
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used to refer to the whole heterotrimeric holoenzyme
complex, while the individual subunits are referred to
by their unique protein name. Sea urchin kinesin-II is
comprised of an approx. 85 kDa (spKRP85) and an
approx. 95 kDa (spKRP95) motor subunit that to-
gether form a heterodimer that often is tightly asso-
ciated with an approx. 115 kDa (spKAP115) non-
motor accessory subunit (Fig. 1). Homologues of
sea urchin heterotrimeric kinesin-II components
have subsequently been identi¢ed in species ranging
from Chlamydomonas to humans (see Table 1).
Where tested, the motor subunits translocate along
microtubules at a rate of approx. 0.4 Wm/s [5]. The
carboxyl terminal portions of the motor subunits in-
teract with the non-motor accessory protein [6,7].
While a function has not been demonstrated for
the accessory subunit, it is believed to function in
either interaction with cargo or regulation of motor
activity. For a more in-depth description of the
structure of kinesin-II see a recent review by Scholey
[8].
The nomenclature used to name the di¡erent kine-
sin-II subunits is di¡erent for each species and often
leads to confusion. In Table 1 the names of all of the
subunits that have been identi¢ed either through pu-
ri¢cation of the holoenzyme or by molecular cloning
of the DNA sequence as well as the name of the
corresponding mouse homologue are provided. Kine-
sin-II holoenzymes in which direct interaction of the
two di¡erent motor subunits has been established by
puri¢cation in every organism listed except for Dro-
sophila (Table 1). In Drosophila, KLP64D and
KLP68 are the sequence homologues of KIF3A
and KIF3B, but evidence for direct interaction be-
tween them has not been reported.
Additional KIF3 motor subunits have been iden-
ti¢ed in mammals (KIF3C) and in Caenorhabditis
elegans (Osm3) that are distinct from the classical
kinesin-II subunits. KIF3C is a neuronally enriched
KIF3 motor subunit that is slightly larger than
KIF3B. Immunoprecipitation of KIF3C protein es-
tablished that KIF3C is able to form a heterodimer
with KIF3A, but not KIF3B [9,10]. Interestingly,
KIF3C protein is distributed between two peaks in
a sucrose gradient, one that is identical to the KIF3A
peak and the other not. This result suggests that
KIF3C can either form a homodimer or may interact
with an unidenti¢ed KIF3 family member [10]. Im-
munoprecipitation and sucrose gradient experiments
established that C. elegans OSM-3 protein, unlike
KIF3C, does not form a complex with either of the
other kinesin-II motor subunits [11]. However, like
KIF3C, it is unclear whether OSM-3 forms a homo-
dimer or a heterodimer with another KIF3 family
member [11].
While the cargo of kinesin-II remains elusive, work
in Chlamydomonas demonstrates that FLA-10 trans-
ports ‘rafts’ composed of a 16S protein complex con-
taining 15 di¡erent polypeptides [12^14] (Table 2).
The raft complex is transported from the basal
body to the tip of the £agella by FLA-10 [12^14]
and then returned to the cell body by dynein
[15,16]. Potential homologues of some of the raft
subunits have been identi¢ed in other species suggest-
ing that use of the raft complex is not unique to
Chlamydomonas. For example, sequence homologues
have been identi¢ed for the p52 subunit in C. elegans
(OSM-6) and in mammals (NGD5) and for the p172
subunit in C. elegans (OSM-1). C. elegans OSM-6
and OSM-1 mutants exhibit the same ciliary defects
observed in OSM-3 mutants, strongly supporting the
notion that these proteins are indeed the functional
homologues of their corresponding Chlamydomonas
raft subunits.
3. Kinesin-II and ciliary transport in invertebrates
The best-established function of kinesin-II is its
role in ciliary transport. Di¡erential interference con-
trast (DIC) microscopy has been used to observe
bidirectional movement of granule-like molecules be-
neath the £agellar membrane in Chlamydomonas.
This movement has been termed intra£agellar trans-
port or IFT and particles can be observed translocat-
ing between the cell body and tip of the £agella
[17,18]. When Chlamydomonas cells that have a tem-
perature sensitive mutation in FLA-10, the homo-
logue of the kinesin-II KIF3A subunit, are shifted
to the restrictive temperature, IFT ceases and the
£agella shorten and eventually disappear [12,13,19].
It is now apparent that kinesin-II is responsible for
transport of the raft complex and perhaps transport
of the components used for cilia construction and
maintenance to the tip of the £agella [12^14]. Dynein
transports rafts and other proteins from the tip of
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the £agella back to the cell body [15,16]. For a more
detailed discussion on ciliary and intra£agellar trans-
port, see a recent review by Rosenbaum et al. [20].
The use of kinesin-II in ciliary transport is not
restricted to the motile £agella of Chlamydomonas
cells, but has also been found in other organisms.
In sea urchin embryos, when function-blocking anti-
bodies against the spKRP85 subunit are injected into
one cell stage embryos, normal cilia fail to be gener-
ated [21]. The cilia that are constructed are short and
immotile, and exhibit large nodules at their tips. This
result suggests that sea urchin ciliary construction is
di¡erent from Chlamydomonas £agellar construction
in that sea urchin embryos may use a kinesin-II in-
dependent mechanism to ¢rst extend a procilium. A
second possibility is that the kinesin-II complex is
Fig. 1. Structure of kinesin-II. Kinesin-II is composed of two di¡erent motor subunits that in mouse have been named KIF3A and
KIF3B. The motor domain interacts with microtubules and contains the ATPase used to translocate the holoenzyme along the micro-
tubules. The coiled-coil stalk is where the two motor subunits interact with each other to form a stable heterodimer. The tail domains
interact with the KAP3 non-motor accessory subunit. KAP3 is believed to either interact with the kinesin-II cargo, or possibly regu-
late motor activity.
Table 1
Members of the KIF3 (kinesin-II) family of kinesins
Organism Name Mouse homologue Dimeric partner Ref.
Chlamydomonas FLA-10 KIF3A KIF3B-like [12,19]
KIF3B-like KIF3B FLA-10
KAP3-like KAP3
Sea urchin SpKRP85 KIF3A SpKRP95 [5,7,40]
SpKRP95 KIF3B SpKRP85
SpKAP115 KAP3
C. elegans CeKRP85 KIF3A ceKRP95 [11,25,26]
CeKRP95 KIF3B ceKRP85
CeKRP115 KAP3
CeOSM3 ceOSM3
Drosophila KLP64D KIF3A KLP68D?? [39,55]
KLP68D KIF3B KLP64D??
Xenopus KIF3A-like KIF3A Xklp3 [47,48,56]
XKLP3 KIF3B KIF3A-like
KAP3-like KAP3
Mouse KIF3A KIF3B or KIF3C [6,9,10,41^43]
KIF3B KIF3A
KIF3C KIF3A
KAP3
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only partially inhibited by the antibody allowing for
partial function of kinesin-II. Regardless, this result
indicates that kinesin-II is essential for the construc-
tion of full length functioning cilia in the early sea
urchin embryo and provides evidence that the kine-
sin-II ciliary transport pathway is not restricted to
Chlamydomonas. Additionally, kinesin-II protein is
present along the £agella of rat spermatids [22] and
the midpiece and £agellum of sea urchin and sand
dollar sperm [23], indicating that all motile cilia may
utilize kinesin-II for ciliary transport.
The ¢rst evidence that kinesin-II is also used in the
construction and maintenance of immotile sensory
cilia was obtained by studying C. elegans mutants
that are incapable of avoiding osmotic di¡erences
in their environment [24]. Many of these mutants
were found to have defective sensory cilia in the neu-
rons that are exposed to the external environment.
Both kinesin-II and OSM-3 localize to these sensory
cilia as detected by immuno£uorescence suggesting
that like their Chlamydomonas homologues, these
complexes might function in transport along the cilia
[11]. Indeed, mutations in the Osm3 gene result in
worms that are missing their sensory cilia, thus pro-
viding genetic evidence that kinesin-II is needed to
construct even immotile cilia [25,26].
In an elegant study, Orozco et al. [27] have shown
that when either a GFP-OSM-6 or a GFP-KAP fu-
sion protein is expressed in C. elegans sensory neu-
rons, each protein is observed translocating along the
sensory cilia. Each fusion protein translocates with a
rate of 0.6 Wm/s and is consistent with the known in
vitro rate of kinesin-II. This is a very powerful ex-
periment that supports two very important conclu-
sions. First, it provides direct visualization of a raft
component moving along the sensory cilium and sec-
ond, it strongly supports the hypothesis that the raft
complex interacts with kinesin-II.
4. Kinesin-II ciliary transport in vertebrates
While it is clear that invertebrates utilize kinesin-II
in ciliary construction and maintenance, until re-
cently it was unknown whether vertebrates also use
kinesin-II in ciliary transport. This question was an-
swered by generating mice that possess a deletion of
either the KIF3A or KIF3B gene [28^30]. The ¢rst
ciliated cells within the embryo are found in the em-
bryonic node where each cell possesses a single cil-
ium that is ¢rst detected around embryonic day 7.5
[31^33]. The embryonic node is important in estab-
lishment of left-right asymmetry [31^33], and inter-
estingly, in humans [34] and mice [35], there has been
a persistent correlation of left-right asymmetry de-
fects with adult ciliary defects.
Deletion of either the KIF3A or KIF3B gene re-
sults in embryos that are missing the cilium that is
normally present on every nodal cell [28^30]. In ad-
dition, embryos subsequently exhibit bilateral or no
expression of the molecular markers of the left-right
determination pathway (i.e. Pitx2, lefty-2), and ran-
domization of cardiac looping before the embryos
die at embryonic day 10.5, thus making a connection
between embryonic nodal cilia and left-right asym-
metry. Wild type nodal cilia are chiral and may be
normally motile. The chiral movement of the cilia
and the architecture of the node together have been
proposed to produce a net £ow of £uid toward the
left side of the node [29,30]. This £ow may enrich an
unknown morphogen to one side of the embryo by
their concerted movement where it can then interact
with an unknown receptor thus establishing the ¢rst
asymmetry within the embryo. In KIF3 null animals,
the cilia are absent and ‘nodal £ow’ is lost, therefore
the initial left-right asymmetry is never established
Table 2
Polypeptide subunits of the raft complex in Chlamydomonas
and the identi¢ed sequence homologues in C. elegans and
mouse (adapted from Ref. [12])
Chlamydomonas C. elegans Mouse
Complex A p144
p140
p139
p122
Complex B p172 OSM-1
p88
p81
p80
p74
p72
p57/p55
p52 OSM-6 NGD5
p46
p27
p20
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[28^30]. While this is a very attractive model, further
experimentation is needed to assess its validity. Addi-
tionally, mutant embryos exhibit anterior-posterior
defects, neurological defects and severe growth retar-
dation ¢rst noticeable at day 8.5^9.0, which may be
independent of or secondary to the ciliary defects
[28^30].
5. Kinesin-II and photoreceptor transport
While it is clear that C. elegans use the kinesin-II
transport pathway for their immotile sensory cilia, it
is unclear whether mammalian immotile sensory cilia
(e.g. photoreceptor cell) also use this pathway. KIF3
family members have been shown biochemically and
by immuno£uorescence to be present in the connect-
ing cilia of photoreceptors from many di¡erent spe-
cies [36,37]. However, there is no evidence that kine-
sin-II actually functions in ciliary transport in these
cells. In fact, KIF3A protein is also present in the
ribbon synapses of photoreceptors at a much higher
concentration than along the connecting cilium, sug-
gesting it may have a role in axonal transport or
synaptic transmission [38].
6. Neuronal functions for KIF3 family members
There is quite a bit of evidence that suggests that
kinesin-II may be an anterograde motor used to
transport vesicular cargoes from neuronal cell bodies
to axonal terminals. During Drosophila melanogaster
embryogenesis, KLP64D and KLP68D mRNA is
most abundant in neurons of the central nervous
system and a subset of peripheral nervous system
neurons, suggesting a function in axonal transport
[39]. In fact, KLP68D protein is restricted primarily
to cholinergic neurons. KLP64D mutants fail to
transport choline acetyltransferase out of their cell
bodies, suggesting that kinesin-II in neurons may
transport soluble proteins along axons [54].
In C. elegans, two di¡erent kinesin-II complexes
have been identi¢ed and the expression of both is
restricted primarily to neurons. Germline transfor-
mation of worms with Osm3:lacZ and Osm3:GFP
fusion proteins result in detectable signal exclusively
within 26 chemosensory neurons [11,26]. When the
same experiment was performed with the kinesin-II
subunits ceKRP95:GFP and ceKAP:GFP, signal
was detected throughout the nervous system includ-
ing the chemosensory neurons [11]. Staining of
worms with antibodies to ceKRP95 and OSM-3
identi¢ed strong signal within the ciliated region of
the chemosensory neurons and punctate staining
throughout the nervous system [11]. This punctate
staining is very similar to the membranous vesicle
staining that has been observed in sea urchin em-
bryos [40] and mouse neurons [9,10,38,41^43] and
supports a role for kinesin-II in transport of mem-
branous cargoes in axons and during mitosis.
In mouse, all three kinesin motor subunits,
KIF3A, KIF3B and KIF3C, are expressed in most
neuronal cell types throughout the nervous system,
suggesting that kinesin-II might have a role in axonal
transport [9,10,38,41^43]. Biochemical and immuno-
£uorescent experiments indicate that while a portion
of the motor pool interacts with membranous
vesicles, a large portion of the protein appears to
be soluble [9,10,38,41,42]. All three KIF3 motor sub-
units accumulate on the proximal side of a sciatic
nerve ligation, which is consistent with each motor
subunit participating in anterograde axonal transport
[9,41,42]. However, the identity of the cargo(es) is
not known at this time, except that the potential
cargo is not the same synaptic vesicle precursors
that are transported by KIF1A [41]. Interestingly,
KIF3A was found to be highly enriched in the syn-
aptic ribbon of photoreceptor cells, suggesting that
kinesin-II might be responsible for delivery of synap-
tic components to these synapses [38]. Further ex-
periments (i.e. gene knockout or cargo identi¢cation)
will need to be conducted to establish the functions
kinesin-II is performing in axonal transport.
7. Kinesin-II involvement in melanophore transport
A role for kinesin-II in the transport of pigment
granules (melanosomes) has recently been identi¢ed
in Xenopus melanophores. Melanosomes aggregate
and disperse along microtubules in response to the
concentration of intracellular cAMP, which can be
altered by melatonin (aggregation) and melanocyte
stimulating hormone (MSH) (dispersion) [44,45].
These observations suggest that microtubule motors
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are most likely responsible for the movement of the
melanosomes within the cell. Indeed, when melano-
somes are biochemically puri¢ed from melanophores,
they are capable of bidirectional movement along
microtubules [46]. Interestingly, in vitro and in vivo
movement of melanosomes is not exclusively unidir-
ectional during periods of aggregation or dispersion.
While melanosomes will tend toward one direction,
they will occasionally reverse their direction for a
short period of time, indicating that counteracting
plus and minus end directed motors are both present.
Rogers et al. [46] found that kinesin-II and dynein
both co-purify with Xenopus melanosomes suggesting
that they might be the motors responsible for the
transport of melanosomes to the plus ends (kinesin-
II) and minus ends (dynein) of microtubules.
Experiments by Tuma et al. provide functional
data that kinesin-II is responsible for transporting
melanosomes to the plus end of microtubules [47].
They expressed a dominant negative form of Xklp3
consisting of the stalk and tail domain, but lacking
the motor domain in melanophores to determine
whether pigment dispersion would be a¡ected. The
transfected cells were treated with melatonin to ag-
gregate melanosomes and subsequently with MSH to
disperse the melanosomes. Cells expressing mutant
Xklp3 do not exhibit melanosome dispersion, sup-
porting the conclusion that kinesin-II is the motor
responsible for melanosome dispersion.
It will be interesting to see whether kinesin-II is
responsible for pigment granule movement in other
pigmented cells, or whether this is a specialized func-
tion for Xenopus melanophores. The most exciting
consequence of these results is that in vitro melano-
some movement can be used in conjunction with
biochemical, cell biological and genetic techniques
to identify kinesin-II interacting proteins as well as
the signaling cascade used to regulate kinesin-II ac-
tivity.
8. Kinesin-II involvement in the secretory transport
pathway
Evidence from a series of provocative experiments
suggests that kinesin-II may be involved in transport-
ing proteins from the ER to the Golgi apparatus [48].
Le Bot et al. [48] provide biochemical and immuno-
£uorescent evidence that wild type Xklp3 (a KIF3B
homologue) co-localizes primarily with vesicles of the
so-called intermediate compartment, which exists be-
tween the ER and Golgi in cultured frog XL177
epithelial cells. Upon treatment with brefeldin A
(BFA), Xklp3 staining was found to partially co-lo-
calize with vesicular structures that also stained for
the KDEL receptor, but not with any Golgi markers,
further suggesting that Xklp3 is not a Golgi associ-
ated motor.
Le Bot et al. also performed a series of experi-
ments in which they expressed the same dominant
negative Xklp3 that was used by Tuma et al. [47]
in an A6 frog epithelial cell line. Surprisingly, in cells
expressing the mutant Xklp3, both wild type and
mutant kinesin-II interaction with vesicular struc-
tures is lost. In these transfected cells, the structure
of the Golgi apparatus is unaltered, but staining of
O-linked glycosylated proteins by a lectin from Helix
pomatia is no longer detected. This lack of staining
by the H. pomatia lectin is also observed when pro-
tein synthesis is inhibited in wild type cells. From
these experiments, the authors suggest that kinesin-
II is not required to maintain the structure or local-
ization of the Golgi apparatus within the cell, but
rather is required for delivery of components of the
glycosylation machinery and/or substrates to the cis-
Golgi from the ER.
This result is surprising since cytoplasmic dyneins
are believed to be responsible for the movement of
vesicles from the ER to Golgi in most cells [49]. In
most cells, the Golgi apparatus co-localizes with the
microtubule-organizing center (MTOC), where the
minus ends of microtubules are situated. In these
cells, minus end directed motors transport vesicles
from the ER to the Golgi apparatus. However, in
polarized epithelial cells the minus ends of microtu-
bules are located near the apical surface. Golgi stacks
are often located near the nucleus, away from the
minus ends, thus making possible the use of a plus
end directed motor for ER to Golgi tra⁄cking.
While the microtubule polarity and organization
have not been established in A6 or XL177 cells,
they may retain microtubule organization that is ob-
served in normal polarized epithelial cells.
Since kinesin-II does not appear to have a role in
Golgi localization, its function may be to counteract
the activity of dynein to transport vesicles from the
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ER, through the so-called intermediate compartment
to the cis-Golgi in polarized cells. While Le Bot et al.
[48] did not show that kinesin-II and dynein function
antagonistically to each other, this antagonism ap-
pears to occur in other kinesin-II pathways. It will
be interesting to know whether kinesin-II performs a
similar ER to Golgi tra⁄cking function in other cell
types and organisms or whether this function is
unique to the frog polarized epithelial cells types
used in this study.
Additional circumstantial evidence for kinesin-II
involvement in Golgi tra⁄cking comes from the lo-
calization of neuronally enriched KIF3C. KIF3C
was found to co-localize with the Golgi marker gian-
tin in neurons [9], but no functional studies have
been reported showing that KIF3C or kinesin-II is
an active participant in ER to Golgi tra⁄cking in
these or any other cells in any organisms besides
Xenopus.
9. Evidence for KIF3 family involvement in mitosis
There is limited evidence that raises the possibility
that kinesin-II has some function during cell division.
In Chlamydomonas, FLA-10 protein is most abun-
dant near the centrioles and the mitotic spindle in
cells that are undergoing mitosis [50], which could
signal a function in mitotic spindle formation and/
or possibly involvement in spindle dynamics during
mitosis. This hypothesis is supported by the identi¢-
cation of several temperature sensitive FLA-10 al-
leles, in combination with mutant alleles at the
APM1 locus, that display synthetic cell division de-
fects [51]. However, none of these FLA-10 or AMP1
mutants exhibit cell division defects on their own.
Similar evidence for kinesin-II involvement in mi-
tosis was obtained in early stage sea urchin embryos.
SpKRP85 protein is present on the mitotic apparatus
of dividing sea urchin embryos, where it co-localizes
with detergent extractable vesicles [40]. However, the
association of kinesin-II with the mitotic apparatus is
transient, not continuing beyond the early cell divi-
sions. In these early sea urchin embryos, kinesin-II
could be responsible for delivering vesicular material
and membranes to the prospective cleavage furrow.
Further evidence for kinesin-II involvement in mi-
tosis was obtained from a yeast two-hybrid screen in
which the human spKAP115 homologue, SMAP
(Smg GDS-associated protein), was found to interact
with HCAP (human chromosome-associated poly-
peptide). Shimizu et al. suggest that SMAP may in-
teract with mitotic chromosomes through HCAP and
has a role in tethering chromosomes to the spindle or
chromosome movement [52,53]. However, there are
no functional data that support this conclusion.
While it is possible that kinesin-II performs some
specialized or minor role in mitosis, three sets of
experiments suggest that kinesin-II is not an essential
mitotic kinesin. First, injection of a kinesin-II anti-
body that inhibits motor activity into sea urchin em-
bryos does not have any deleterious e¡ects on mitosis
in these cells [21]. Second, mouse embryos lacking
either motor subunit of kinesin-II develop normally
until embryonic day 8, indicating that normal cell
division occurs without functioning kinesin-II [28^
30]. Third, Drosophila larvae that lack either kine-
sin-II motor subunit do not exhibit mitotic defects
[54]. While an essential role for kinesin-II during
mitosis is doubtful, more in-depth analysis will be
needed to determine whether there are any subtle
mitotic defects in cells that are missing or have de-
fective kinesin-II subunits.
10. Unresolved issues about kinesin-II function
Since the initial identi¢cation of kinesin-II in sea
urchin, kinesin-II homologues have been identi¢ed in
almost every species examined. Studying these homo-
logues has aided in the identi¢cation of many di¡er-
ent potential functions for the kinesin-II motor com-
plex in numerous contexts. In the future, these
potential functions will need to be more closely dis-
sected to determine whether a function identi¢ed in
one cell type and organism applies to other cell types
or organisms. While there is convincing evidence that
kinesin-II has a role in ciliary construction and main-
tenance in numerous cell types and organisms, its
role in membrane vesicle transport in axons and dur-
ing mitosis and its role in ER to Golgi transport are
less well understood. The latter may represent highly
specialized functions of the kinesin-II complex and
may not be applicable to all cell types or organisms.
Important future questions include: How is the
motor activity of kinesin-II regulated? What are
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the cargoes of kinesin-II and how is their interaction
regulated? Does kinesin-II interact with ‘raft’ com-
plexes in non-ciliated cells like neurons? Are defects
in components of the kinesin-II ciliary transport
pathway responsible for human ciliary defects? Since
kinesin-II homologues exist in almost every eukary-
otic organism examined, exploitation of the strengths
of each experimental system should make answering
many of these questions easier.
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